Literature DB >> 25429104

Structural features of membrane-bound glucocerebrosidase and α-synuclein probed by neutron reflectometry and fluorescence spectroscopy.

Thai Leong Yap1, Zhiping Jiang1, Frank Heinrich2, James M Gruschus1, Candace M Pfefferkorn1, Marilia Barros3, Joseph E Curtis4, Ellen Sidransky5, Jennifer C Lee6.   

Abstract

Mutations in glucocerebrosidase (GCase), the enzyme deficient in Gaucher disease, are a common genetic risk factor for the development of Parkinson disease and related disorders, implicating the role of this lysosomal hydrolase in the disease etiology. A specific physical interaction exists between the Parkinson disease-related protein α-synuclein (α-syn) and GCase both in solution and on the lipid membrane, resulting in efficient enzyme inhibition. Here, neutron reflectometry was employed as a first direct structural characterization of GCase and α-syn·GCase complex on a sparsely-tethered lipid bilayer, revealing the orientation of the membrane-bound GCase. GCase binds to and partially inserts into the bilayer with its active site most likely lying just above the membrane-water interface. The interaction was further characterized by intrinsic Trp fluorescence, circular dichroism, and surface plasmon resonance spectroscopy. Both Trp fluorescence and neutron reflectometry results suggest a rearrangement of loops surrounding the catalytic site, where they extend into the hydrocarbon chain region of the outer leaflet. Taking advantage of contrasting neutron scattering length densities, the use of deuterated α-syn versus protiated GCase showed a large change in the membrane-bound structure of α-syn in the complex. We propose a model of α-syn·GCase on the membrane, providing structural insights into inhibition of GCase by α-syn. The interaction displaces GCase away from the membrane, possibly impeding substrate access and perturbing the active site. GCase greatly alters membrane-bound α-syn, moving helical residues away from the bilayer, which could impact the degradation of α-syn in the lysosome where these two proteins interact.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Gaucher Disease; Membrane Bilayer; Parkinson Disease; Protein-Lipid Interaction; Surface Plasmon Resonance (SPR); Tryptophan

Mesh:

Substances:

Year:  2014        PMID: 25429104      PMCID: PMC4295019          DOI: 10.1074/jbc.M114.610584

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  Structure and dynamics of micelle-bound human alpha-synuclein.

Authors:  Tobias S Ulmer; Ad Bax; Nelson B Cole; Robert L Nussbaum
Journal:  J Biol Chem       Date:  2004-12-22       Impact factor: 5.157

2.  Investigating the interactions of the 18kDa translocator protein and its ligand PK11195 in planar lipid bilayers.

Authors:  Claire R Hatty; Anton P Le Brun; Vanessa Lake; Luke A Clifton; Guo Jun Liu; Michael James; Richard B Banati
Journal:  Biochim Biophys Acta       Date:  2013-12-27

3.  CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy.

Authors:  S Pablo Sardi; Jennifer Clarke; Cathrine Kinnecom; Thomas J Tamsett; Lingyun Li; Lisa M Stanek; Marco A Passini; Gregory A Grabowski; Michael G Schlossmacher; Richard L Sidman; Seng H Cheng; Lamya S Shihabuddin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

Review 4.  Principles of lysosomal membrane digestion: stimulation of sphingolipid degradation by sphingolipid activator proteins and anionic lysosomal lipids.

Authors:  Thomas Kolter; Konrad Sandhoff
Journal:  Annu Rev Cell Dev Biol       Date:  2005       Impact factor: 13.827

Review 5.  Zooming in on disordered systems: neutron reflection studies of proteins associated with fluid membranes.

Authors:  Frank Heinrich; Mathias Lösche
Journal:  Biochim Biophys Acta       Date:  2014-03-25

6.  Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders.

Authors:  Ozlem Goker-Alpan; Barbara K Stubblefield; Benoit I Giasson; Ellen Sidransky
Journal:  Acta Neuropathol       Date:  2010-09-14       Impact factor: 17.088

7.  Emerging insights into the mechanistic link between α-synuclein and glucocerebrosidase in Parkinson's disease.

Authors:  Ryan P McGlinchey; Jennifer C Lee
Journal:  Biochem Soc Trans       Date:  2013-12       Impact factor: 5.407

Review 8.  The many faces of α-synuclein: from structure and toxicity to therapeutic target.

Authors:  Hilal A Lashuel; Cassia R Overk; Abid Oueslati; Eliezer Masliah
Journal:  Nat Rev Neurosci       Date:  2013-01       Impact factor: 34.870

9.  Lysosomal degradation on vesicular membrane surfaces. Enhanced glucosylceramide degradation by lysosomal anionic lipids and activators.

Authors:  G Wilkening; T Linke; K Sandhoff
Journal:  J Biol Chem       Date:  1998-11-13       Impact factor: 5.157

10.  Low resolution structure and dynamics of a colicin-receptor complex determined by neutron scattering.

Authors:  Luke A Clifton; Christopher L Johnson; Alexandra S Solovyova; Phil Callow; Kevin L Weiss; Helen Ridley; Anton P Le Brun; Christian J Kinane; John R P Webster; Stephen A Holt; Jeremy H Lakey
Journal:  J Biol Chem       Date:  2011-11-10       Impact factor: 5.157

View more
  17 in total

1.  Effects of phosphatidylcholine membrane fluidity on the conformation and aggregation of N-terminally acetylated α-synuclein.

Authors:  Emma I O'Leary; Zhiping Jiang; Marie-Paule Strub; Jennifer C Lee
Journal:  J Biol Chem       Date:  2018-05-31       Impact factor: 5.157

2.  Role of GSK3β/α-synuclein axis in methamphetamine-induced neurotoxicity in PC12 cells.

Authors:  Lizeng Li; Si Chen; Yue Wang; Xia Yue; Jingtao Xu; Weibing Xie; Pingming Qiu; Chao Liu; AiFeng Wang; Huijun Wang
Journal:  Toxicol Res (Camb)       Date:  2017-12-22       Impact factor: 3.524

3.  Information gain from isotopic contrast variation in neutron reflectometry on protein-membrane complex structures.

Authors:  Frank Heinrich; Paul A Kienzle; David P Hoogerheide; Mathias Lösche
Journal:  J Appl Crystallogr       Date:  2020-05-29       Impact factor: 3.304

Review 4.  Glucocerebrosidase as a therapeutic target for Parkinson's disease.

Authors:  Yu Chen; Richard Sam; Pankaj Sharma; Lu Chen; Jenny Do; Ellen Sidransky
Journal:  Expert Opin Ther Targets       Date:  2020-02-27       Impact factor: 6.902

5.  Coupling X-Ray Reflectivity and In Silico Binding to Yield Dynamics of Membrane Recognition by Tim1.

Authors:  Gregory T Tietjen; Javier L Baylon; Daniel Kerr; Zhiliang Gong; J Michael Henderson; Charles T R Heffern; Mati Meron; Binhua Lin; Mark L Schlossman; Erin J Adams; Emad Tajkhorshid; Ka Yee C Lee
Journal:  Biophys J       Date:  2017-10-03       Impact factor: 4.033

Review 6.  The Complicated Relationship between Gaucher Disease and Parkinsonism: Insights from a Rare Disease.

Authors:  Elma Aflaki; Wendy Westbroek; Ellen Sidransky
Journal:  Neuron       Date:  2017-02-22       Impact factor: 17.173

7.  Segmental Deuteration of α-Synuclein for Neutron Reflectometry on Tethered Bilayers.

Authors:  Zhiping Jiang; Frank Heinrich; Ryan P McGlinchey; James M Gruschus; Jennifer C Lee
Journal:  J Phys Chem Lett       Date:  2016-12-09       Impact factor: 6.475

8.  Membrane Interactions of α-Synuclein Probed by Neutrons and Photons.

Authors:  Upneet Kaur; Jennifer C Lee
Journal:  Acc Chem Res       Date:  2021-01-08       Impact factor: 22.384

Review 9.  Biomembrane Structure and Material Properties Studied With Neutron Scattering.

Authors:  Jacob J Kinnun; Haden L Scott; Rana Ashkar; John Katsaras
Journal:  Front Chem       Date:  2021-04-27       Impact factor: 5.221

10.  Lysosomal integral membrane protein-2 as a phospholipid receptor revealed by biophysical and cellular studies.

Authors:  Karen S Conrad; Ting-Wen Cheng; Daniel Ysselstein; Saskia Heybrock; Lise R Hoth; Boris A Chrunyk; Christopher W Am Ende; Dimitri Krainc; Michael Schwake; Paul Saftig; Shenping Liu; Xiayang Qiu; Michael D Ehlers
Journal:  Nat Commun       Date:  2017-12-04       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.